Health Care & Hospitals

Black Women’s Health Imperative Celebrates 40 Years of Empowering Black Women with inaugural State of Black Women Science Summit and Homecoming Tour

by

ATLANTA, May 26, 2023 /PRNewswire/ — In celebration of its forty years as the only national organization focused on Black women’s health and wellness, BWHI will return to its local chapter roots this fall, hosting large-scale “homecoming”-themed celebrations designed to educate, empower, and advocate on behalf of Black women and girls’ health and wellness.  These … Read more

ProfoundBio Announces Further Advancement of Lead Programs

by

PRO1160 first patient dosed in the US China NMPA clearance for PRO1184 (rinatabart sesutecan, Rina-S) and PRO1160 to initiate clinical trials Rina-S preliminary clinical data is encouraging SUZHOU, China and WOODINVILLE, Wash., May 26, 2023 /PRNewswire/ — ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics, announced that dosing in the Phase … Read more

Bulletin from the Annual General Meeting in Immunovia AB

by

LUND, Sweden, May 26, 2023 /PRNewswire/ — On 26th May 2023, an Annual General Meeting (AGM) was held in Immunovia AB (publ), 556730-4299 at The Spark, Scheeletorget 1, Medicon Village, in Lund. Below is a summary of the resolutions made at the AGM. Allocation of the company’s available profits and discharge from liability The AGM resolved … Read more

ConcertAI’s TeraRecon adds Prostate Cancer Detection/Diagnosis into Eureka Clinical AI Platform with Bot Image, Inc. Partnership

by

CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians with the state-of-the-art clinical artificial intelligence and deep learning technology necessary to bring fast and accurate prostate cancer detection and diagnosis using bpMRI and AI in partnership with Bot Image, … Read more

SPRIM Global Investments Pte. Ltd. completes equity investment in UK specialist clinical trial site, VCTC Ltd.

by

SINGAPORE, May 26, 2023 /PRNewswire/ — SPRIM Global Investments (SPRIM), a leading health sciences investment firm, completed an equity investment in VCTC Limited, a UK-based specialist clinical trial site. SPRIM funding will enable VCTC to expedite growth through expansion of services and access to wider cross-portfolio opportunities. This investment is part of SPRIM’s strategy to … Read more

Ascentage Pharma Presents Updated Results from Multiple Clinical Studies at American Society of Clinical Oncology Annual Conference

by

SUZHOU, China, and ROCKVILLE, Md., May 25, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that 4 of its abstracts were selected for presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. These studies … Read more

Growing Consumer Awareness Towards Health Benefits of Allergy Immunotherapies Fuels the Sector

by

DUBLIN, May 25, 2023 /PRNewswire/ — The “Allergy Immunotherapies Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to  ResearchAndMarkets.com’s offering. The global allergy immunotherapies market is expected to grow at a CAGR of around 9.4% during 2023-2030. Companies Mentioned  Aimmune Therapeutics ALK-Abello A/S Allergy Therapeutics Anergis SA Biomay AG Circassia … Read more

California’s Best Cannabis Takes the Stage at BottleRock 2023

by

Celebrate California Cannabis at this Educational Event by Traditional, Embarc and Abide NAPA, Calif., May 25, 2023 /PRNewswire/ — Renowned festival BottleRock is celebrating a new era with “The Garden,” an onsite cannabis activation facilitating education and awareness by some of the best brands in California. The Garden will provide festival goers the opportunity to … Read more

Daewoong Pharmaceutical veröffentlicht den molekularen Mechanismus von Bersiporocin als Antifibrotikum in der EMBO Molecular Medicine

by

Aufgeklärter molekularer Mechanismus hinter der Sicherheit und Wirksamkeit von Bersiporocin Bersiporocin befindet sich derzeit in einer klinischen Studie der Phase II zur Behandlung der idiopathischen Lungenfibrose SEOUL, Südkorea, 26. Mai 2023 /PRNewswire/ — Daewoong Pharmaceutical (CEO Lee Chang-jae und Jeon Sengho) gab am 25. Mai bekannt, dass der molekulare Mechanismus hinter der Sicherheit und Wirksamkeit … Read more

Huma named for its successful and innovative approach to clinical trials in new UK government review

by

Huma’s innovative approach to medical research cited in Lord James O’Shaughnessy’s review for clinical trials improvement in the UK The review is part of a new widespread policy approach to ignite the UK’s life sciences sector Innovating clinical trials using digital technologies such as Huma’s platforms can make them more accessible, more diverse, faster to … Read more